Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 12:19 PM
Ignite Modification Date:
2025-12-26 @ 12:19 PM
NCT ID:
NCT01025700
Brief Summary:
Safety of Nabilone in reducing marijuana craving
Detailed Description:
Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use
Study:
NCT01025700
Study Brief:
Protocol Section:
NCT01025700